Sunshine Insurance Leads ~USD96m Series B for China’s Xuanzhu Biopharm

Sunshine Insurance led a CNY600m (~USD96m) Series B for China-based biopharma Xuanzhu Biopharm, with participation from Efung Capital, Zhongji Investment, TJ Capital, SDIC Taikang, Haichuang FOF, Bank of China Capital, Jinjiang Xuanhong, Shanxi Financial Holdings, Wanxin Capital, DNV Capital and HY Capital. Read more… Read More

INCE Capital Closes on USD700m Across Two Funds

INCE Capital reached final closes for INCE Capital Partners II and INCE Opportunity Fund, raising USD478m and USD222m, respectively. INCE’s second fund will focus on early-stage opportunities at the nexus of consumer and internet, while the opportunity vehicle will target later-stage investments. Read more… Read More



(default archive template)